YMTX

Yumanity Therapeutics (YMTX)

Yumanity Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:YMTX

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/12/17	04 : 58	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/17	00 : 38	Edgar (US Regulatory)	Sec Staff Action/letter (sec Staff)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/15	20 : 43	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/14	06 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/07	06 : 56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/07	06 : 53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/07	06 : 52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/07	06 : 05	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/07	06 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/05	23 : 29	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/05	23 : 28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/05	21 : 30	GlobeNewswire Inc.	Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/02	06 : 05	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/16	06 : 04	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/16	06 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/14	22 : 45	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/14	22 : 38	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/14	22 : 16	GlobeNewswire Inc.	Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developments	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/14	20 : 09	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/11	06 : 27	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/11	06 : 15	GlobeNewswire Inc.	Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/05	05 : 53	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/27	20 : 16	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/27	20 : 14	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/27	06 : 19	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/27	06 : 18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/27	06 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/24	22 : 17	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/24	21 : 02	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/24	20 : 59	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc